CryoLife (Germany) Today
| CYL Stock | EUR 26.60 1.00 3.91% |
Performance10 of 100
| Odds Of DistressOver 52
|
CryoLife is trading at 26.60 as of the 24th of November 2024. This is a 3.91 percent increase since the beginning of the trading day. The stock's lowest day price was 26.6. CryoLife has 52 percent odds of going through some form of financial distress in the next two years but had a very ok returns during the last 90 days. Equity ratings for CryoLife are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 25th of October 2024 and ending today, the 24th of November 2024. Click here to learn more.
CryoLife, Inc., together with its subsidiaries, manufactures, processes, and distributes medical devices and implantable human tissues for use in cardiac and vascular surgeries worldwide. CryoLife, Inc. was founded in 1984 and is headquartered in Kennesaw, Georgia. The company has 40.56 M outstanding shares. More on CryoLife
Moving together with CryoLife Stock
| 0.66 | ABL | Abbott Laboratories | PairCorr |
| 0.69 | ABL | Abbott Laboratories | PairCorr |
| 0.71 | SYK | Stryker | PairCorr |
| 0.73 | BSX | Boston Scientific | PairCorr |
Moving against CryoLife Stock
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
CryoLife Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. CryoLife's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding CryoLife or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| Business Concentration | Medical Devices, Healthcare (View all Sectors) |
CryoLife (CYL) is traded on Frankfurt Exchange in Germany and employs 1,300 people. The company currently falls under 'Small-Cap' category with a current market capitalization of 506.16 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate CryoLife's market, we take the total number of its shares issued and multiply it by CryoLife's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. CryoLife classifies itself under Healthcare sector and is part of Medical Devices industry. The entity has 40.56 M outstanding shares.
CryoLife has accumulated about 40.26 M in cash with (5.15 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.08.
Check CryoLife Probability Of Bankruptcy
Ownership AllocationCryoLife holds a total of 40.56 Million outstanding shares. The majority of CryoLife outstanding shares are owned by other corporate entities. These outside corporations are usually referred to as non-private investors looking to acquire positions in CryoLife to benefit from reduced commissions. Consequently, institutional investors are subject to a different set of regulations than regular investors in CryoLife. Please pay attention to any change in the institutional holdings of CryoLife as this could imply that something significant has changed or is about to change at the company. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check CryoLife Ownership Details
CryoLife Risk Profiles
Although CryoLife's alpha and beta are two of the key measurements used to evaluate CryoLife's performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 1.32 | |||
| Semi Deviation | 1.29 | |||
| Standard Deviation | 1.7 | |||
| Variance | 2.89 |
CryoLife Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in CryoLife without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Latest Portfolios Now
Latest PortfoliosQuick portfolio dashboard that showcases your latest portfolios |
| All Next | Launch Module |
CryoLife Corporate Management
Elected by the shareholders, the CryoLife's board of directors comprises two types of representatives: CryoLife inside directors who are chosen from within the company, and outside directors, selected externally and held independent of CryoLife. The board's role is to monitor CryoLife's management team and ensure that shareholders' interests are well served. CryoLife's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, CryoLife's outside directors are responsible for providing unbiased perspectives on the board's policies.
| CPA CPA | VP Officer | Profile | |
| James Mackin | Pres Chairman | Profile | |
| Dennis Maier | VP Operations | Profile | |
| Joshua Wells | Sr Devel | Profile | |
| Marshall MD | VP Officer | Profile | |
| Jean Esq | Gen VP | Profile | |
| John Davis | VP Marketing | Profile |
Other Information on Investing in CryoLife Stock
CryoLife financial ratios help investors to determine whether CryoLife Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in CryoLife with respect to the benefits of owning CryoLife security.